Free Trial

Korea Investment CORP Increases Stock Holdings in The Clorox Company $CLX

Clorox logo with Consumer Staples background

Key Points

  • Korea Investment CORP increased its stake in The Clorox Company by 40.7%, owning 27,685 shares worth approximately $4.08 million after buying an additional 8,013 shares.
  • Clorox recently announced a quarterly dividend of $1.24 per share, reflecting a dividend yield of 4.1% and an increase from the previous dividend of $1.22.
  • Analysts have varied price targets for Clorox, with an average target price of $143.36, and ratings span from "Buy" to "Sell" with most classified as "Hold".
  • Need better tools to track Clorox? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Korea Investment CORP grew its position in The Clorox Company (NYSE:CLX - Free Report) by 40.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,685 shares of the company's stock after acquiring an additional 8,013 shares during the quarter. Korea Investment CORP's holdings in Clorox were worth $4,077,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Wood Tarver Financial Group LLC acquired a new stake in shares of Clorox in the fourth quarter valued at approximately $31,000. GW&K Investment Management LLC boosted its holdings in shares of Clorox by 239.1% in the first quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock valued at $43,000 after acquiring an additional 208 shares during the period. Roble Belko & Company Inc boosted its holdings in shares of Clorox by 140.7% in the first quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock valued at $53,000 after acquiring an additional 211 shares during the period. Menard Financial Group LLC acquired a new stake in shares of Clorox during the fourth quarter worth $63,000. Finally, IMA Advisory Services Inc. acquired a new stake in shares of Clorox during the first quarter worth $58,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently weighed in on CLX shares. Barclays decreased their price target on Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a report on Tuesday, July 15th. JPMorgan Chase & Co. decreased their price target on Clorox from $144.00 to $140.00 and set a "neutral" rating for the company in a report on Friday, July 25th. Wells Fargo & Company increased their price target on Clorox from $135.00 to $138.00 and gave the stock an "equal weight" rating in a report on Friday, August 1st. Citigroup reaffirmed a "neutral" rating and set a $135.00 price target (down from $140.00) on shares of Clorox in a report on Tuesday, July 15th. Finally, UBS Group cut their price objective on Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a research report on Thursday, July 17th. One analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and three have issued a Sell rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Reduce" and a consensus price target of $143.36.

Get Our Latest Stock Analysis on CLX

Clorox Price Performance

Shares of CLX stock traded up $1.28 during mid-day trading on Wednesday, reaching $118.95. The stock had a trading volume of 1,789,454 shares, compared to its average volume of 1,642,632. The Clorox Company has a 12-month low of $117.35 and a 12-month high of $171.37. The company has a market cap of $14.55 billion, a P/E ratio of 18.24, a price-to-earnings-growth ratio of 0.95 and a beta of 0.49. The business has a 50-day simple moving average of $124.08 and a 200 day simple moving average of $134.89. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating analysts' consensus estimates of $2.24 by $0.63. The business had revenue of $1.99 billion during the quarter, compared to analysts' expectations of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business's revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter last year, the business posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, sell-side analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Wednesday, August 13th will be paid a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a yield of 4.2%. The ex-dividend date of this dividend is Wednesday, August 13th. This is a positive change from Clorox's previous quarterly dividend of $1.22. Clorox's dividend payout ratio is 76.07%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: All Signs Point to More Growth Ahead
3 Quiet Growth Stocks With Major Momentum
The Market’s Next Big Winners? Start Here

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines